CTSO READ THE FULL CTSO RESEARCH REPORT 3rd Quarter 2025 Financial & Operating Results CytoSorbents (NASDAQ:CTSO) reported 3rd quarter 2025 financial and operating results which exceeded our ...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...
An announcement from Strategy ( ($MSTR) ) is now available. On November 17, 2025, Strategy Inc announced updates regarding its at-the-market ...
Leonardo reported a remarkable 24.3% increase in new orders year-over-year, reaching over EUR 18 billion. Revenue also saw a substantial rise, growing by 12.4% to EUR 13.4 billion. This growth ...
Energy Resources of Australia (ASX:ERA), a particularly diluted stock for its $1.01 billion market cap, added 25% to 0.3c a ...